Pages

Friday, August 1, 2014

Seattle Genetics Reports Second Quarter 2014 Financial Results

The company also highlighted ADCETRIS commercialization and clinical development accomplishments, progress with its antibody-drug conjugate pipeline, collaborator updates and upcoming activities.

http://ift.tt/1tDll2y

No comments:

Post a Comment